{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:24:01Z","timestamp":1787127841348,"version":"build-2736575974"},"reference-count":17,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UMICA121974"],"award-info":[{"award-number":["UMICA121974"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY002687"],"award-info":[{"award-number":["P30 EY002687"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ophtha.2026.05.011","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:23:54Z","timestamp":1787124234000},"page":"1068-1070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic Antiviral Therapy for Ocular Zoster (with or without the Zoster Eye Disease Study Data)"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8620-2708","authenticated-orcid":false,"given":"Todd P.","family":"Margolis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2026.05.011_bib1","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/infdis\/jiz652","article-title":"The epidemiology of herpes zoster in immunocompetent, unvaccinated adults \u2265 50 years old: incidence, complications, hospitalization, mortality, and recurrence","volume":"222","author":"Tseng","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2026.05.011_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2024.06.003","article-title":"Herpes zoster ophthalmicus recurrence: risk factors and long-term clinical outcomes","volume":"268","author":"Scott","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.05.011_bib3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/jiad609","article-title":"Unraveling the immune signature of herpes zoster: insights into the pathophysiology and human leukocyte antigen risk profile","volume":"230","author":"Vandoren","year":"2024","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ophtha.2026.05.011_bib4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jcv.2010.10.014","article-title":"Persistence of varicella zoster virus viraemia in patients with herpes zoster","volume":"50","author":"Quinlivan","year":"2011","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.05.011_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ajo.2009.08.030","article-title":"Late varicella-zoster virus dendriform keratitis in patients with histories of herpes zoster ophthalmicus","volume":"149","author":"Hu","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.05.011_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1080\/09273948.2024.2435477","article-title":"Clinical features of varicella-zoster virus-associated anterior uveitis with or without ophthalmic herpes zoster","volume":"33","author":"Seki","year":"2025","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2026.05.011_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41433-023-02630-9","article-title":"The infectious uveitis treatment algorithm network (TITAN) report 1\u2014global current practice patterns for the management of herpes simplex virus and varicella zoster virus anterior uveitis","volume":"38","author":"Thng","year":"2024","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.ophtha.2026.05.011_bib8","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0002-9394(14)76725-X","article-title":"Decrease in the risk of bilateral acute retinal necrosis by acyclovir therapy","volume":"112","author":"Palay","year":"1991","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ophtha.2026.05.011_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00003226-199303000-00007","article-title":"Detection of varicella zoster virus DNA and viral antigen in human cornea after herpes zoster ophthalmicus","volume":"12","author":"Wenkel","year":"1993","journal-title":"Cornea"},{"issue":"17","key":"10.1016\/j.ophtha.2026.05.011_bib10","first-page":"2062","article-title":"How I prevent viral reactivation in high-risk patients","volume":"141","author":"Dadwal","year":"2023","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ophtha.2026.05.011_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/jamaophthalmol.2024.6114","article-title":"Low-dose valacyclovir in herpes zoster ophthalmicus: the zoster eye disease randomized clinical trial","volume":"143","author":"Cohen","year":"2025","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.ophtha.2026.05.011_bib12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaophthalmol.2025.0204","article-title":"Zoster Eye Disease Study","volume":"143","author":"Jabs","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2026.05.011_bib13","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archopht.1996.01100140267002","article-title":"A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus","volume":"114","year":"1996","journal-title":"Arch Ophthamol"},{"key":"10.1016\/j.ophtha.2026.05.011_bib14","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1056\/NEJM199807303390503","article-title":"Acyclovir for the prevention of recurrent herpes simplex virus eye disease","volume":"339","year":"1998","journal-title":"N Eng J Med"},{"issue":"3","key":"10.1016\/j.ophtha.2026.05.011_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ophtha.2025.10.018","article-title":"Analysis of the zoster eye disease study using original end point criteria","volume":"133","author":"Jeng","year":"2026","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ophtha.2026.05.011_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ophtha.2025.09.002","article-title":"Bayesian analysis of valacyclovir treatment effect in the zoster eye disease study","volume":"133","author":"Jeng","year":"2026","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ophtha.2026.05.011_bib17","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/ICO.0000000000002754","article-title":"Herpes zoster: a brief definitive review","volume":"40","author":"Cohen","year":"2021","journal-title":"Cornea"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026003581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642026003581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:25:06Z","timestamp":1787124306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642026003581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0161642026003581"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.05.011","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Antiviral Therapy for Ocular Zoster (with or without the Zoster Eye Disease Study Data)","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2026.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Ophthalmology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}